期刊文献+

B型钠尿肽评估腹膜透析患者干体质量的临床意义 被引量:1

下载PDF
导出
摘要 目的探讨血钠尿肽(BNP)水平在慢性肾衰竭腹膜透析患者干体质量评估中的临床意义。方法分别测定40例慢性肾衰竭腹膜透析患者和30例对照组血BNP水平。结果腹膜透析患者达到干体质量组血BNP水平与正常对照组无显著差异(P>0.05),而未达到干体质量组血BNP水平与正常对照组有显著差异(P<0.05)。结论血BNP水平对于腹膜透析患者干体质量评估有重要意义。
出处 《实用心脑肺血管病杂志》 2012年第4期667-668,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
基金 佛山市卫生局医学科研立项课题[2011155]
  • 相关文献

参考文献5

  • 1Woodrow G. Can we improve fluid balance and cardiovascular outcomes in peritoneal dialysis patients[J].Peritoneal Dialysis International,2006.49-52.
  • 2Chen W,Cheng LT,Wang T. Salt and fluid intake in the development of hypertension in peritoneal patients[J].Renal Failure,2007.427-432.
  • 3Schirmer H,Omland T. Circulating N-terminal proatrial natriuretic peptide is an independent predictor of left ventricular hypertrophy in the general population[J].European Heart Journal,1999.755-763.
  • 4Zooccall C,Mallamaci F,Benedetto FA. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients[J].Journal of the American Society of Nephrology,2001.1508-1515.
  • 5Morici ML,Di Marco A,Traina M. Plasma levels of atrial natri-uretic peptide and hemodynamic function in cardiac disease[J].International Journal of Cardiology,1993.15-20.doi:10.1016/0167-5273(93)90097-Z.

同被引文献13

  • 1Sheen V,Bhalla V,Tulua-Tata A,et al.The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease[J].Am Heart J, 2007,153 (2) : 244. el-244.e5.
  • 2Celik G,Silinou E,Vo-Van C,et al.Plasma BNP,a useful marker of fluid overload in hospitalized hemodialysis pa-tients[J].Hemodial Int,2012,16( 1 ) :47-52.
  • 3Vitturi N,Dugo M,Soattin M,et al.Lung uhrasound during hemodialysis:the role in the assessment of volume status[J]. Int Urol Nephrol,2014,46( 1 ) : 169-174.
  • 4Moissl U,Arias-Guill6n M,Wabel P,et aLBioimpedance- guided fluid management in hemodialysis patients[J].Clin J Am Soc Nephrol,2013,8(9) : 1575-1582.
  • 5Thijssen S, Kappel F, Kotanko P.Absolute blood volume in hemodialysis patients:why is it relevant,and how to mea- sure it?[J].Blood Purif, 2013,35 ( 1-3 ) :63-71.
  • 6Paniagua R,Ventura MD,Avila-Diaz M,et aLNT-proBNP, fluid volume overload and dialysis modality are indepen- dent predictors of mortality in ESRD patients [J].Nephrol Dial Transplant, 2010, 25 (2) : 551-557.
  • 7Tapolyai M,Uysal A,Maeweathers G,et al.B-type natri- uretic peptide-directed ultrafihration improves care in a- cutely hospitalized dialysis patients[J].Congest Heart Fail, 2009,15(3) : 131-135.
  • 8Booth J,Pinney J,Davenport A.N-terminal proBNP-- marker of cardiac dysfunction,fluid overload,or malnutri- tion in hemodialysis patients?[J].Clin J Am Soc Nephrol, 2010,5(6) :1036-1040.
  • 9Roueff S,Martin E,Chauffert ML,et al.Brain natriuretic peptide variations are linked to volume status in hemodial- ysis patients[J].Clin Nephrol, 2008,70 (6) : 508-513.
  • 10Odar-CederlSf I,Bjellerup P,Williams A,et al.Daily dialyses decrease plasma levels of brain natriuretic pep- tide(BNP),a biomarker of left ventricular dysfunction[J]. Hemodial Int, 2006,10 (4) : 394-398.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部